The FDA sorts medical devices into three classes by the risk they pose to the patient: Class I (low risk, mostly exempt from premarket review), Class II (moderate risk, usually requiring 510(k) clearance), and Class III (high risk, requiring full premarket approval). One of the first questions any medical device founder must answer is which class their product falls into — because the answer determines the depth of documentation, the length of the regulatory process, the development budget, and sometimes the entire business model. A low-class device can reach the market in months; a Class III device can take years and clinical data. That's why classification should be settled before the first line is drawn, not after. This article is educational — Projects House is an engineering firm, not a law firm or regulatory consultancy — but classification is where every one of our medical projects begins.

What Actually Determines the Class

Classification is driven by risk to the patient, not by technological complexity. Three factors dominate: how invasive the device is, how long it stays in contact with the body, and whether it supports or sustains a vital function. A digital thermometer or an orthopedic support touches the body externally and briefly — low risk. An infusion pump delivers substances into the body — a step up. An implanted pacemaker whose failure can kill — the highest tier. One more principle worth knowing: if the device produces a diagnosis that drives a critical treatment decision, its class can rise even if it never touches the patient. The system is essentially a hierarchy ranking each device by the severity of potential harm and the probability it occurs.

The Three Classes in Practice

  • Class I — low risk. Subject to general controls: establishment registration, device listing, proper labeling, and quality requirements. Most Class I devices are exempt from premarket submission. Examples: manual instruments, supports, external measuring tools.
  • Class II — moderate risk. Usually requires a 510(k) submission demonstrating substantial equivalence to a device already on the market, plus performance testing, electrical safety, and electromagnetic compatibility. This is where most innovative hardware devices land.
  • Class III — high risk. Implants and life-sustaining devices. Requires premarket approval (PMA) with a full evidence package, usually including a dedicated clinical study — the longest and most expensive pathway.

For a genuinely novel low-to-moderate-risk device with no predicate to point to, the De Novo pathway offers a route to a Class I or II designation without a PMA. Note that this three-class system is the US framework; the European system uses a parallel but different structure, so a global launch plan needs both mapped out.

How Classification Is Determined in Practice

It starts with writing a precise intended use statement: what the device does, for whom, who operates it, and in what environment. Precise wording here is the strongest tool a founder has. An overly broad statement pulls the device up the risk ladder; a focused one can keep it in a lower class without sacrificing customer value. Next, search the FDA's classification database and product codes for similar devices already cleared — how they were classified is usually the most reliable indicator for yours. In parallel, run an early risk analysis: mapping the possible failure modes sometimes exposes a hazard you hadn't considered that changes the class. If your product includes an algorithm or companion app, software-as-a-medical-device rules deserve early attention too — software has become a leading source of regulatory surprises.

What the Class Means for Design and Engineering

Once the class is known, it dictates the engineering process. At low risk you can work relatively flexibly and move fast to a prototype. From moderate risk upward, development must run under design controls: documented requirements, verification and validation, change control, and a record of every decision. Material selection is affected as well — any component contacting the body needs biocompatibility evidence. The budget implication is stark: the gap between a low-class and high-class pathway can be several multiples of the total cost, which is why classification is really the decision that shapes the entire work plan. We break the numbers down in how much FDA approval costs and what it costs to develop a medical device, and the build side in medical device prototyping. More guides live in our medical device development hub.

Not sure which class your device belongs to, or want the engineering planned to match the regulatory pathway from day one? Contact Projects House and we'll help you build a realistic regulatory-and-engineering roadmap for your device.